The cell lines we used include the McNeuA Her2-positive41, 4T1 triple-negative breast cancer (TNBC)42, and Met1 TNBC43 murine mammary carcinoma cell lines, as well as the human HMLER-HR TNBC cell line44. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.